Novartis Investigative Site

Bayonne, Bayonne Cedex 64109

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia, Heart Failure With Preserved Ejection Fraction, Multiple Myeloma

Studies at this site

• Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients — Completed
• Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma — Completed
• A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML) — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed